by Rose Trapnell, Queensland University of Technology Credit: Queensland University of Technology A QUT researcher’s identification of saliva as an early detection liquid biopsy for oral and throat cancer has been realized by the development and commercialisation of a diagnostic device by US-based biotech company Viome. Viome’s early detection device has been designated a Breakthrough Device...